A. P. Rauter et al.
FULL PAPER
78.4 (C-4), 77.8 (C-3), 75.9 (C-3Ј), 75.0, 73.4, 71.7 (OCH2Ph), 70.7
(C-5), 69.0 (C-6), 56.7 (C-14Ј), 56.1 (C-17Ј), 50.1 (C-9Ј), 42.3
(C-13Ј), 40.0 (C-4Ј), 39.8 (C-12Ј), 39.5 (C-24Ј), 37.1 (C-1Ј), 36.7
(C-10Ј), 36.2 (C-22Ј), 36.0 (C-2), 35.8 (C-20Ј), 31.9 (C-8Ј), 28.2
(C-16Ј), 28.0 (C-25Ј), 27.7 (C-2Ј), 24.3 (C-15Ј), 23.8 (C-23Ј), 22.8
(C-27Ј), 22.6 (C-26Ј), 21.0 (C-19Ј), 19.3 (C-11Ј), 18.7 (C-21Ј), 11.9
(C-18Ј) ppm. HRMS: calcd. for C54H74O5 802.553732; found
802.553625.
44.6 (C-3Ј), 35.3 (C-2) ppm. HRMS: calcd. for C42H40O7
656.275482; found 656.277405.
(2ЈR)-/(2ЈS)-Flavanon-7-yl 3,4,6-Tri-O-benzyl-2-deoxy-α-
D-arabino-
hexopyranoside (7a): Reaction of with 7-hydroxyflavanone
1
(480 mg, 2 mmol) gave 7a as a syrup (459 mg, 70%), with the start-
ing material 1 being recovered in 14% yield (59 mg); Rf = 0.42
(EtOAc/n-hexane, 1:3). IR (neat): ν = 1689 cm–1 (C=O). UV: λmax
˜
1
(ε) = 345 nm (4341), 258 (8328). H NMR (400.13 MHz, CDCl3,
3
25 °C): δ = 7.86 (d, J5Ј,6Ј = 8.8 Hz, 1 H, 5Ј-H), 7.45–7.19 (m, 20
Lanosteryl 3,4,6-Tri-O-benzyl-2-deoxy-α-D-arabino-hexopyranoside
H, Ph), 6.75–6.70 (m, 2 H, 6Ј-H, 8Ј-H), 5.74 (br. s, 1 H, 1-H), 5.47–
(5): Reaction of 1 with lanosterol (853 mg, 2 mmol) for 60 min gave
5 as a syrup (346 mg, 43%); Rf = 0.53 (EtOAc/n-hexane, 1:2).
2
5.41 (m, 1 H, 2Ј-H), 4.92, 4.90 (part A of AB system, JAB
=
[α]2D0 = +66 (c = 1, CH Cl ). IR (neat): ν = 1600 cm–1 (C=C, Ph).
10.8 Hz, 1 H, OCH2Ph), 4.75–4.43 (m, 5 H, OCH2Ph), 4.15 (ddd,
˜
2
2
3J2ax,3 = 10.8, 3J2eq,3 = 4.8, 3J3,4 = 9.0 Hz, 1 H, 3-H), 3.82–3.48 (m,
UV: λmax (ε) = 247 nm (1843), 230 (1968). 1H NMR (500.13 MHz,
2
4 H, 4-H, 5-H, 6-H), 3.02 (dd, 3J2Ј,3Јax = 13.2, J3Јax,3Јeq = 16.8 Hz,
CDCl3, 25 °C): δ = 7.47–7.27 (m, 15 H, Ph), 5.26 (d, 3J1,2a = 3.0 Hz,
1 H, 1-H), 5.21 (br. t, J23Ј,24Ј = 6.0 Hz, 1 H, 24Ј-H), 5.01, 4.97
(part A of AB system, JAB = 10.8 Hz, 1 H, OCH2Ph), 4.76–4.57
(m, 5 H, OCH2Ph), 4.15 (ddd, J2ax,3 = 11.1, J2eq,3 = 4.8, J3,4
3
2
3
1 H, 3Јax-H), 2.84 (dd, J2Ј,3Јeq = 2.4, J3Јax,3Јeq = 16.8 Hz, 1 H,
2
3
2
3Јeq-H), 2.46 (dd, J2ax,2eq = 13.2, J2eq,3 = 4.8 Hz, 1 H, 2eq-H),
1.90 (ddd, 3J1,2ax = 2.2, 2J2ax,2eq = 13.2, 3J2ax,3 = 10.8 Hz, 1 H, 2ax-
H) ppm. 13C NMR (100.62 MHz, CDCl3, 25 °C): δ = 190.8 (C-4,
C=O), 163.3 163.0 (C-8Јa, C-7Ј), 162.8 (C-4Јa), 138.8, 138.5, 138.3,
137.9 (Cq, Ph), 128.5 (C-5Ј), 128.8, 128.4, 127.9, 127.7, 126.2, 126.1
(CH-Ph), 111.3, 103.9 (C-6Ј, C-8Ј) 95.9 (C-1), 79.8 (C-2Ј), 77.6
(C-4), 77.2 (C-3), 75.1, 73.4, 72.1 (OCH2), 72.0 (C-5), 68.4 (C-6),
44.5 (C-3Ј), 35.1 (C-2) ppm. HRMS: calcd. for C42H40O7
656.275482; found 656.277406.
3
3
3
=
=
3
3
3
9.0 Hz, 1 H, 3-H), 4.02 (ddd, J4,5 = 10.2, J5,6A = 3.6, J5,6B
1.8 Hz, 1 H, 5-H), 3.88 (dd, 3J5,6A = 3.6, 2J6A,6B = 10.5 Hz, 1 H, 6A-
H), 3.76–3.68 (m, 2 H, 4-H, 6B-H), 3.22 (dd, 3J2ЈA,3Ј = 3.3, 3J2ЈB,3Ј
=
2
3
11.1 Hz, 1 H, 3Ј-H), 2.27 (dd, J2ax,2eq = 12.3, J2eq,3 = 4.8 Hz, 1
H, 2eq-H), 1.68, 1.60 (each s, 3 H, 26Ј-H, 27Ј-H), 0.98 (s, 3 H, 19Ј-
H), 0.96, 0.80 (each s, 3 H, 28Ј-H, 29Ј-H), 0.92 (d, 3J20Ј,21Ј = 7.0 Hz,
3 H, 21Ј-H), 0.88 (s, 3 H, 30-H), 0.69 (s, 3 H, 18Ј-H) ppm. 13C
NMR (125.77 MHz, CDCl3, 25 °C): δ = 139.2, 139.0, 138.7 (Cq,
Ph), 134.9 (C-9Ј), 134.8 (C-8Ј), 131.3 (C-25Ј), 130.2, 128.8, 128.7,
128.5, 128.4, 128.3, 128.2, 128.0, 127.9 (CH, Ph), 125.7 (C-24Ј),
93.7 (C-1), 82.1 (C-3Ј), 79.0 (C-4), 78.1 (C-3), 75.4, 73.9, 72.2
(OCH2Ph), 71.8 (C-5), 69.4 (C-6), 51.1 (C-5Ј), 50.8 (C-17Ј), 50.2
(C-13Ј), 44.9 (C-14Ј), 38.9 (C-10Ј), 37.4 (C-4Ј), 36.8 (C-23Ј), 35.6
(C-1Ј), 31.5 (C-12Ј), 29.1 (C-29Ј), 26.2, 18.1 (C-26Ј, C-27Ј), 36.9,
36.6, 31.3, 30.2, 28.7, 26.9, 25.4, 24.7, 23.0, 18.7 (C-2Ј, C-2, C-6Ј,
C-7Ј, C-11Ј, C-15Ј, C-16Ј, C-20Ј, C-22Ј, C-30Ј), 19.7 (C-19Ј), 19.1
(C-21Ј), 16.8 (C-28Ј), 16.2 (C-18Ј) ppm. C57H78O5 (843.23): calcd.
C 81.19, H 9.32; found C 81.43, H 9.18.
(2ЈR)-/(2ЈS)-Flavanon-4Ј-yl 3,4,6-Tri-O-benzyl-2-deoxy-α/β-D-arab-
ino-hexopyranoside (8a,b): Reaction of 1 with 4Ј-hydroxyflavanone
(480 mg, 2 mmol) gave 8a as a syrup (376 mg, 57%, in dichloro-
methane), with the starting material 1 being recovered in 20% yield
(82 mg), or 8a,b as a syrup (257 mg, 39%, in THF under reflux, α/
β = 8.8/1, with the starting material 1 being recovered in 8%
(33 mg); Rf = 0.40 (EtOAc/n-hexane, 1:3).
8a: IR (neat): ν = 1698 cm–1 (C=O). UV: λmax (ε) = 325.5 nm
˜
(8000), 280.0 (2246), 256.5 (8000). 1H NMR (400.13 MHz, CDCl3,
3
4
25 °C): δ = 7.94 (dd, J5Ј,6Ј = 7.6, J5Ј,7Ј = 1.6 Hz, 1 H, 5Ј-H), 7.51
(td, 4J5Ј,7Ј = 1.6, 3J7Ј,8Ј = 3J6Ј,7Ј = 8.4 Hz, 1 H, 7Ј-H), 7.40–7.17 (m,
18 H, Ph), 7.11 (d, J2ЈЈ,3ЈЈ = J5ЈЈ,6ЈЈ = 8.0 Hz, 2 H, 3ЈЈ-H, 5ЈЈ-H),
7.08–6.98 (m, 2 H, 6Ј-H, 8Ј-H), 5.74 (d, J1,2ax = 2.4 Hz, 1 H, 1-
H), 5.44 (dd, J2Ј,3Јax = 13.6, J2Ј,3Јeq = 2.4 Hz, 1 H, 2Ј-H), 4.96,
3
3
(2ЈR)-/(2ЈS)-Flavanon-6-yl 3,4,6-Tri-O-benzyl-2-deoxy-α,β-D-arab-
3
ino-hexopyranoside (6a,b): Reaction of 1 with 6-hydroxyflavanone
(480 mg, 2 mmol) gave 6a as a syrup {358 mg (54%) in dichloro-
methane [167 mg (25%) in THF at room temp.], the starting mate-
rial 1 being recovered in 21% yield (88 mg) in dichloromethane
[32% (133 mg) in THF at room temp. for 180 min]} or 6a,b as a
syrup [405 mg (62%) in THF under reflux for 180 min, α/β = 4.6/
1, with 75 mg (18%) of the starting material 1 being recovered]; Rf
= 0.43 (EtOAc/n-hexane, 1:5).
3
3
2
4.92 (part A of AB system, JAB = 12.0 Hz, OCH2Ph), 4.79 – 4.45
(m, 5 H, OCH2Ph), 4.22 (td, 3J2eq,3 = 4.8, 3J2ax,3 = 3J3,4 = 10.5 Hz,
1 H, 3-H), 3.88–3.76 (m, 3 H, 4-H, 5-H, 6A-H), 3.62 (dd, 2J6A,6B
=
10.5, 3J5,6 = 5.1 Hz, 1 H, 6B-H), 3.10 (dd, 2J3Јax,3Јeq = 16.8, J2Ј,3Јax
3
3
2
= 13.5 Hz, 1 H, 3Јax-H), 2.89 (dd, J2Ј,3Јeq = 2.4, J3Јax,3Јeq
16.8 Hz, 1 H, 3Јeq-H), 2.51 (dd, J2ax,2eq = 12.8, J2eq,3 = 4.8 Hz,
1 H, 2eq-H), 1.93 (ddd, J1,2ax = 2.4, J2ax,2eq = 12.8, J2ax,3
=
2
3
3
2
3
=
6a: IR (neat): ν = 1698 cm–1 (C=O). UV: λmax (ε) = 345 nm (4341),
˜
10.5 Hz, 1 H, 2ax-H) ppm. 13C NMR (100.62 MHz, CDCl3,
25 °C): δ = 192.2 (C-4Ј, C=O), 161.6 (C-8Јa), 156.9 (C-4ЈЈ), 138.5,
138.4, 138.0 (Cq, Ph), 136.2 (C-7Ј), 132.0 (C-1ЈЈ), 128.5, 128.4,
128.1, 127.9, 127.7 (CH-Ph), 127.1 (C-5Ј), 121.6 (C-6Ј), 120.9
(C-4Јa), 118.1 (C-8Ј), 116.6 (C-3ЈЈ, C-5ЈЈ), 95.9 (C-1), 79.4 (C-2Ј),
75.2, 73.4, 72.0 (OCH2), 71.3 (C-4), 68.6 (C-5), 68.5 (C-6), 44.5
(C-3Ј), 35.4 (C-2) ppm. HRMS: calcd. for C42H40O7 656.27759;
found 656.277405.
258 (8328). 1H NMR (400.13 MHz, CDCl3, 25 °C): δ = 7.61 (d,
4J5Ј,7Ј = 2.0 Hz, 1 H, 5Ј-H), 7.45–7.18 (m, 21 H, 4 Ph, 7-ЈH), 6.97
(d, 3J7Ј,8Ј = 8.8 Hz, 1 H, 8Ј-H), 5.67 (br. s, 1 H, 1-H), 5.43–5.37 (m,
2
1 H, 2Ј-H), 4.94, 4.91 (part A of AB system, JAB = 12.0 Hz, 1 H,
2
OCH2Ph), 4.76, 4.73, 4.72, 4.69 (AB system, JAB = 11.6 Hz, 2 H,
2
OCH2Ph), 4.63, 4.60, 4.56, 4.53 (AB system, JAB = 12.0 Hz, 2 H,
2
OCH2Ph), 4.47, 4.44 (part B of AB system, JAB = 12.0 Hz, 1 H,
3
3
3
OCH2Ph), 4.17 (td, J3,4 = J2ax,3 = 9.0, J2eq,3 = 4.8 Hz, 1 H, 3-
H), 3.87–3.60 (m, 4 H, 4-H, 5-H, 6A-H, 6B-H), 3.07–2.98 (m, 1 H, Methyl
(3,4,6-Tri-O-benzyl-2-deoxy-α-
D-arabino-hexopyranosyl)-
2
3Јax-H), 2.88 (br. d, J3Јax,3Јeq = 16.8 Hz, 1 H, 3Јeq-H), 2.48 (dd, (1Ǟ3)-2-O-benzoyl-4,6-di-O-benzylidene-α-
D-glucopyranoside (9):
3
3
2J2ax,2eq = 12.8, J2eq,3 = 4.8 Hz, 1 H, 2eq-H), 1.95 (ddd, J1,2ax
=
Reaction of 1 with methyl 2-O-benzoyl-4,6-di-O-benzylidene-α--
glucopyranoside (787 mg, 2 mmol) gave 9 as a syrup (512 mg,
64%); Rf = 0.50 (EtOAc/n-hexane, 1:4). [α]2D0 = +88 (c = 1,
2.2, J2ax,2eq = 12.8, J2ax,3 = 9.0 Hz, 1 H, 2ax-H) ppm. 13C NMR
(100.62 MHz, CDCl3, 25 °C): δ = 191.8 (C-4Ј, C=O), 156.9, 150.93,
150.86 (C-4Ј, C-6Ј, C-8Ј), 138.9, 138.8, 138.6, 138.4, 138.1 (Cq-Ph),
2
3
CH Cl ). IR (neat): ν = 1731 cm–1 (C=O). UV: λmax (ε) = 253 nm
˜
2
2
128.9, 128.5, 128.4, 127.9, 127.8, 127.7, 126.2 (C-7Ј, CH-Ph), 119.2 (1476). 1H NMR (300.14 MHz, CDCl3, 25 °C): δ = 8.08 (d, J =
(C-8Ј), 112.9 (C-5Ј), 96.5 (C-1), 79.8, 79.7 (C-2Ј), 77.9 (C-4) 77.3 8.4 Hz, 2 H, Ph), 7.51–7.27 (m, 21 H, Ph), 7.00 (d, J = 8.4 Hz, 2
(C-3), 75.1, 73.4, 72.0 (OCH2Ph), 71.8 (C-5), 68.6 (C-6), 44.7 or
2436
H, Ph), 5.63 (s, 1 H, CH, benzylidene), 5.56 (br. s, 1 H, 1Ј-H) 5.20
www.eurjoc.org
© 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2006, 2429–2439